Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
522.30
|
|
Change (%)
|
-2.90 (-0.55%)
|
|
Best Buy (RS)
|
522.35(x1)
|
|
Best Sell (RS)
|
524.2(x1)
|
|
Today's Range (RS)
|
517.70
-
522.90
|
|
52-Week Range (RS)
|
490.00
-
789.95
|
|
Beta (1 Year)
|
0.42
|
|
|
|
|
|
| News |
|
Corporate Details |
| Board of Amrutanjan Health Care recommends Final Dividend |
| Amrutanjan Health Care standalone net profit rises 6.65% in the March 2026 quarter |
| Amrutanjan Health Care to discuss results |
|
|
|
| Incoporation Year : 1936 |
| Chairman : S Sambhuprasad |
| Ownership Group : Amrutanjan |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Formulations |
| Registered Office |
Amrutanjan Health Care Ltd
New 103 Old 42-45 LuzChurch Rd,
Mylapore,
Chennai,
Tamil Nadu-600004 |
Phone:91-44-24994164/24994465/24994366
Fax:91-44-24994585 |
| E-Mail : investors@amrutanjan.com; customercare@amrutanjan. |
| URL : http://www.amrutanjan.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
29-Jul-2026 |
516.80 |
1.63 |
| 1Month |
06-Jul-2026 |
531.30 |
-1.15 |
| 3Month |
05-May-2026 |
533.50 |
-1.56 |
| 6Month |
05-Feb-2026 |
629.05 |
-16.51 |
| 1Year |
05-Aug-2025 |
688.35 |
-23.70 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| DSP Small Cap Fund |
0.31 |
60.05 |
| ICICI Pru FMCG Fund |
2.00 |
31.80 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Formulations |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Torrent Pharmaceuticals Ltd |
5,024.35 |
0.53 |
5,249.95 |
3,480.00 |
190,107.85 |
| Ajanta Pharma Ltd |
3,455.90 |
0.51 |
3,598.40 |
2,335.00 |
42,967.16 |
| Gland Pharma Ltd |
2,590.10 |
1.74 |
2,634.00 |
1,575.00 |
41,995.56 |
| Rubicon Research Ltd |
1,568.60 |
-0.40 |
1,589.00 |
571.00 |
26,046.13 |
| Caplin Point Laboratories Ltd |
2,572.50 |
1.15 |
2,700.00 |
1,502.45 |
19,331.67 |
|
|
|
|